GeneDx Holdings (WGS) Income from Non-Controlling Interests (2023 - 2026)
GeneDx Holdings (WGS) posted quarterly Income from Non-Controlling Interests of -$253000.0 for Q1 2026, down 437.33% year-over-year from $75000.0 in Q1 2025, and down 283.33% quarter-over-quarter from -$66000.0 in Q4 2025.
GeneDx Holdings (WGS) Income from Non-Controlling Interests (2023 - 2026) Analysis & Trends
GeneDx Holdings (WGS) has reported Income from Non-Controlling Interests for 4 consecutive years, with -$253000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Income from Non-Controlling Interests fell 437.33% year-over-year to -$253000.0; the TTM figure through Mar 2026 stood at -$222000.0 (down 136.16% YoY), while the FY2025 annual figure was $106000.0, down 73.83% from the prior year.
- Income from Non-Controlling Interests eased to -$253000.0 in Q1 2026 per WGS's latest filing, from -$66000.0 in the prior quarter.
- Across five years, Income from Non-Controlling Interests topped out at $459000.0 in Q3 2024 and bottomed at -$253000.0 in Q1 2026.
- Historically, Income from Non-Controlling Interests has averaged $68300.0 across 4 years, with a median of $4500.0 in 2025.
- Annual changes were most pronounced in 2025 — Income from Non-Controlling Interests soared 155.97% — and 2026, when it plunged 437.33%.
- GeneDx Holdings' Income from Non-Controlling Interests stood at $425000.0 in 2023, then plunged by 120.71% to -$88000.0 in 2024, then climbed by 25.0% to -$66000.0 in 2025, then plunged by 283.33% to -$253000.0 in 2026.
- Business Quant data shows WGS's Income from Non-Controlling Interests at -$253000.0 in Q1 2026, -$66000.0 in Q4 2025, and $190000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.77 Bn | 209.71 Bn | 8.34 Bn | 5.00 Mn |
| 2 | Danaher | 139.78 Bn | 135.43 Bn | 3.61 Bn | - |
| 3 | Idexx Laboratories | 46.04 Bn | 45.85 Bn | 779.09 Mn | - |
| 4 | Agilent Technologies | 39.68 Bn | 37.88 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 39.34 Bn | 37.26 Bn | 1.44 Bn | 2.00 Mn |
| 6 | Natera | 38.75 Bn | 37.65 Bn | 696.04 Mn | - |
| 7 | Illumina | 29.90 Bn | 28.73 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.58 Bn | 28.53 Bn | 650.22 Mn | - |
| 9 | Quest Diagnostics | 26.18 Bn | 25.55 Bn | 1.03 Bn | 14.00 Mn |
| 10 | GeneDx Holdings | 2.08 Bn | 1.95 Bn | 78.24 Mn | -341,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -341,000.00 |
| Mar 31, 2026 | -253,000.00 |
| Dec 31, 2025 | -66,000.00 |
| Sep 30, 2025 | 190,000.00 |
| Jun 30, 2025 | -93,000.00 |
| Mar 31, 2025 | 75,000.00 |
| Dec 31, 2024 | -88,000.00 |
| Sep 30, 2024 | 459,000.00 |
| Jun 30, 2024 | 168,000.00 |
| Mar 31, 2024 | -134,000.00 |
| Dec 31, 2023 | 425,000.00 |